|
SSR3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.663600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.067500E-02 |
| Normal-vs-Stage2 |
6.132800E-01 |
| Normal-vs-Stage3 |
5.651400E-01 |
| Normal-vs-Stage4 |
8.307000E-01 |
| Stage1-vs-Stage2 |
5.367400E-01 |
| Stage1-vs-Stage3 |
1.195960E-02 |
| Stage1-vs-Stage4 |
1.377200E-01 |
| Stage2-vs-Stage3 |
3.892200E-01 |
| Stage2-vs-Stage4 |
5.660800E-01 |
| Stage3-vs-Stage4 |
8.739200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.858600E-01 |
| Normal-vs-AfricanAmerican |
4.787700E-02 |
| Normal-vs-Asian |
4.985400E-01 |
| Caucasian-vs-AfricanAmerican |
4.514100E-02 |
| Caucasian-vs-Asian |
6.331800E-01 |
| AfricanAmerican-vs-Asian |
1.786200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.286600E-01 |
| Normal-vs-Female |
8.414500E-02 |
| Male-vs-Female |
1.824020E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.914500E-02 |
| Normal-vs-Age(41-60Yrs) |
5.516800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.457800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.409400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.553700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.078100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.270830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.713400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.474800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.721800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.844300E-03 |
| Classical-VS-Follicular |
9.446800E-01 |
| Classical-VS-Other |
4.791600E-02 |
| Classical-VS-Normal |
1.224170E-01 |
| Tall-VS-Follicular |
3.325700E-02 |
| Tall-VS-Other |
2.436800E-01 |
| Tall-VS-Normal |
1.099220E-01 |
| Follicular-VS-Other |
1.266610E-01 |
| Follicular-VS-Normal |
3.446800E-01 |
| Other-VS-Normal |
2.850400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.479600E-01 |
| Normal-vs-N1 |
1.939400E-01 |
| N0-vs-N1 |
3.854400E-02 |
|
|
